The software was designed to address issues with inter-reader variability common to LDCT screenings. 

It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. 

Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.

The American College of Radiology recently brought together thought leaders from 32 different organizations to come up with ways to standardize care when using this popular imaging system. 

Both company shareholders and Chinese regulators have approved the sale, with TPG and Blackstone anticipating they'll take the reins by April. 

In other news, NYU Langone Health recently named a new radiation oncology chair, a Lumexa Imaging rad is joining the RSNA board, and SNMMI has appointed an editor for its flagship journal. 

Slow Food NYC gives the “Snail of Approval” honors to restaurants that make high-quality, sustainable food. But on rare occasions, a hospital earns the designation. Northwell Health’s Lenox Hill is the latest.

Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."